Stay updated on Duvelisib in Refractory Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib in Refractory Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    4%
    Check dated 2025-10-06T16:03:40.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Update: citation updated from v3.0.2 to v3.1.0 and addition of an erratum note; essentially a bibliographic metadata precision upgrade rather than a major content change.
    Difference
    0.5%
    Check dated 2025-09-29T09:58:37.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed; no substantive changes to core content.
    Difference
    0.2%
    Check dated 2025-09-15T00:35:02.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T20:55:23.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, while removing several previous location entries and related medical topics.
    Difference
    3%
    Check dated 2025-08-31T12:59:54.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The page has removed a significant study reference regarding Duvelisib in patients with refractory indolent non-Hodgkin lymphoma, which may impact the information available to readers about this treatment option.
    Difference
    0.4%
    Check dated 2025-08-24T09:38:27.000Z thumbnail image

Stay in the know with updates to Duvelisib in Refractory Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.